1 |
DeFilippis EM, Rubin G, Farr MA, Biviano A, Wan EY, Takeda K, Garan H, Topkara VK, Yarmohammadi H. Cardiac Implantable Electronic Devices Following Heart Transplantation. JACC Clin Electrophysiol 2020;6:1028-42. [PMID: 32819520 DOI: 10.1016/j.jacep.2020.06.023] [Reference Citation Analysis]
|
2 |
Duijzer D, de Winter MA, Nijkeuter M, Tuinenburg AE, Westerink J. Upper Extremity Deep Vein Thrombosis and Asymptomatic Vein Occlusion in Patients With Transvenous Leads: A Systematic Review and Meta-Analysis. Front Cardiovasc Med 2021;8:698336. [PMID: 34490367 DOI: 10.3389/fcvm.2021.698336] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Araj FG. Conduction Abnormalities and Tricuspid Regurgitation after Cardiac Transplant: Is a Leadless Pacemaker Part of the Solution? ASAIO J 2020;66:e56. [PMID: 32106170 DOI: 10.1097/MAT.0000000000001113] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
4 |
Nguyen BT, Bhusal B, Rahsepar AA, Fawcett K, Lin S, Marks DS, Passman R, Nieto D, Niemzcura R, Golestanirad L. Safety of MRI in patients with retained cardiac leads. Magn Reson Med 2021. [PMID: 34958685 DOI: 10.1002/mrm.29116] [Reference Citation Analysis]
|
5 |
Fardman A, Ram E, Lavee J, Wieder A, Beinart R, Nof E, Peled Y. Complications of retained pacemaker hardware in heart transplant recipients: case series and review of the literature. Infection 2020;48:635-40. [PMID: 32246271 DOI: 10.1007/s15010-020-01410-x] [Reference Citation Analysis]
|